Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Manus Bio Inc | 37 |
| 2 | Ajinomoto Co Inc | 28 |
| 3 | Massachusetts Institute of Technology | 21 |
| 4 | Goodyear Tire and Rubber Co | 18 |
| 5 | Danisco US Inc | 15 |
| 6 | Agriculture Victoria Services Pty Ltd | 9 |
| 7 | BASF Metabolome Solutions GmbH | 9 |
| 8 | Lanzatech NZ Inc | 8 |
| 9 | University of California San Diego UCSD | 8 |
| 10 | Bridgestone Corp | 7 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C12N | Microorganisms, enzymes | 394 |
| 2 | C12P | Fermentation, enzyme processes | 318 |
| 3 | C12Y | Enzyme nomenclature (EC numbers) | 237 |
| 4 | C07K | Peptides | 70 |
| 5 | C12R | 58 |
| 6 | A61K | Medicinal preparations | 56 |
| 7 | Y02A | Climate change adaptation | 51 |
| 8 | A61P | Therapeutic activity (drug indications) | 40 |
| 9 | Y02E | Climate change mitigation: energy | 37 |
| 10 | C12Q | Measuring/testing involving enzymes | 35 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWhere research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Plant biochemistry and biosynthesis | 4 |
| 2 | Malaria Research and Control | 1 |
| 3 | Microbial Natural Products and Biosynthesis | 1 |
| 4 | Plant-Microbe Interactions and Immunity | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Albert Boronat | Universitat de Barcelona | 10 |
| 2 | Michel Rohmer | Centre National de la Recherche Scientifique | 10 |
| 3 | Denis Tritsch | Centre National de la Recherche Scientifique | 7 |
| 4 | Catherine Grosdemange‐Billiard | Centre National de la Recherche Scientifique | 6 |
| 5 | Manuel Rodrı́guez-Concepción | Universitat de Barcelona | 6 |
| 6 | C. Dale Poulter | University of Utah | 5 |
| 7 | Myriam Seemann | Institut de Chimie | 3 |
| 8 | Andréa Hemmerlin | Institut de Biologie Moléculaire des Plantes | 4 |
| 9 | Audrey Oudin | Université de Tours | 4 |
| 10 | Benoit St‐Pierre | Université de Tours | 4 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Two LysM receptor molecules, CEBiP and OsCERK1, cooperatively regulate chitin elicitor signaling in rice | 2010 | 716 | Plant-Microbe Interactions and Immunity |
| Retrograde Signaling by the Plastidial Metabolite MEcPP Regulates Expression of Nuclear Stress-Response Genes | 2012 | 417 | Photosynthetic Processes and Mechanisms |
| Modular Pathway Engineering of Diterpenoid Synthases and the Mevalonic Acid Pathway for Miltiradiene Production | 2012 | 414 | Microbial Natural Products and Biosynthesis |
| Origins and Early Evolution of the Mevalonate Pathway of Isoprenoid Biosynthesis in the Three Domains of Life | 2010 | 370 | Microbial Natural Products and Biosynthesis |
| Prenylation of aromatic compounds, a key diversification of plant secondary metabolites | 2009 | 319 | Phytochemicals and Antioxidant Activities |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of [(2S,3R)-3,4-dihydroxy-1-methoxybutan-2-yl] dihydrogen phosphate?
Which organizations hold the most patents involving this compound?
What research areas are most associated with patents for this compound?
What academic researchers have published most extensively on topics related to this compound?
How has patent activity for this compound evolved in recent years?